Fig. 6. Mean change in best-corrected visual acuity and central macular thickness at baseline, after last aflibercept injection(A), and after switching to three injections of ranibizumab(R). CMT = central macular thickness; BCVA = best-corrected visual acuity; logMAR = logarithm of the minimum angle of resolution. *p < 0.05.

J Retin 2021;6:99-109 https://doi.org/10.21561/jor.2021.6.2.99

© 2021 J Retin